| 000 | 01488 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513052907.0 | ||
| 264 | 0 | _c19941221 | |
| 008 | 199412s 0 0 eng d | ||
| 022 | _a0301-5149 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aHone, D M | |
| 245 | 0 | 0 |
_aExpression of human immunodeficiency virus antigens in an attenuated Salmonella typhi vector vaccine. _h[electronic resource] |
| 260 |
_bDevelopments in biological standardization _c1994 |
||
| 300 |
_a159-62 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.; Review | ||
| 650 | 0 | 4 |
_aAIDS Vaccines _ximmunology |
| 650 | 0 | 4 |
_aGene Products, nef _xgenetics |
| 650 | 0 | 4 | _aGenetic Vectors |
| 650 | 0 | 4 |
_aHIV Antibodies _xbiosynthesis |
| 650 | 0 | 4 |
_aHIV Antigens _ximmunology |
| 650 | 0 | 4 |
_aHIV Core Protein p24 _xgenetics |
| 650 | 0 | 4 |
_aHIV Envelope Protein gp120 _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMucous Membrane _ximmunology |
| 650 | 0 | 4 | _aPromoter Regions, Genetic |
| 650 | 0 | 4 |
_aRecombinant Fusion Proteins _xgenetics |
| 650 | 0 | 4 |
_aSalmonella typhi _xgenetics |
| 650 | 0 | 4 | _aSequence Deletion |
| 650 | 0 | 4 | _aVaccines, Attenuated |
| 650 | 0 | 4 |
_aVaccines, Synthetic _ximmunology |
| 650 | 0 | 4 | _aVirulence |
| 700 | 1 | _aLewis, G K | |
| 700 | 1 | _aBeier, M | |
| 700 | 1 | _aHarris, A | |
| 700 | 1 | _aMcDaniels, T | |
| 700 | 1 | _aFouts, T R | |
| 773 | 0 |
_tDevelopments in biological standardization _gvol. 82 _gp. 159-62 |
|
| 999 |
_c7957801 _d7957801 |
||